Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)-Reference-Cited by-同舟云学术

Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)

Published:2018-04-30 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Pandith Arshad A.,Qasim Iqbal,Zahoor Wani,Shah Parveen,Bhat Abdul R.,Sanadhya Dheera,Shah Zafar A.,Naikoo Niyaz A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-25169-2.pdf

Reference59 articles.

1. Mao, X. & Hamoudi, R. A. Molecular and cytogenetic analysis of glioblastoma multiforme. Cancer Genet Cytogenet 122, 87–92 (2000).

2. Zhu, A., Shaeffer, J., Leslie, S., Kolm, P. & El-Mahdi, A. M. Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation. Int J Radiat Oncol Biol Phys 34, 809–815 (1996).

3. Jansen, M., Yip, S. & Louis, D. N. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol 9, 717–726, https://doi.org/10.1016/s1474-4422(10)70105-8 (2010).

4. Stupp, R. et al. Changing paradigms–an update on the multidisciplinary management of malignant glioma. Oncologist 11, 165–180, https://doi.org/10.1634/theoncologist.11-2-165 (2006).

5. Mutter, N. & Stupp, R. Temozolomide: a milestone in neuro-oncology and beyond? Expert Rev Anticancer Ther 6, 1187–1204, https://doi.org/10.1586/14737140.6.8.1187 (2006).

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temozolomide cocrystal forms with enhanced dissolution, stability and biological activity towards Glioblastoma;Journal of Molecular Structure;2024-10

2. Unravelling the mosaic: Epigenetic diversity in glioblastoma;Molecular Oncology;2024-08-15

3. MGMT protein expression is a reliable predictive biomarker for temozolomide‐containing chemotherapy in osteosarcoma;Cancer Science;2024-07-30

4. Novel MGMT inhibitors increase the sensitivity of glioma MGMT-positive cells to treatment with alkylating agents in vitro;Biopolymers and Cell;2024-03-20

5. Inhibition of O6‐methylguanine‐DNA‐methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT‐proficient cells;Chemical Biology & Drug Design;2024-01-29